

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.07335631 |
| 2 | DNA deamination (GO:0045006) | 5.51025860 |
| 3 | viral transcription (GO:0019083) | 5.36508578 |
| 4 | translational termination (GO:0006415) | 5.21999415 |
| 5 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.21163223 |
| 6 | DNA strand elongation (GO:0022616) | 4.95689350 |
| 7 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.91954580 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 4.82635219 |
| 9 | translational elongation (GO:0006414) | 4.75539439 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 4.73906397 |
| 11 | DNA unwinding involved in DNA replication (GO:0006268) | 4.68496652 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.63651087 |
| 13 | DNA replication initiation (GO:0006270) | 4.53976631 |
| 14 | protein targeting to ER (GO:0045047) | 4.50147902 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 4.50091136 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 4.50001775 |
| 17 | translational initiation (GO:0006413) | 4.32106435 |
| 18 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.28751122 |
| 19 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.28750712 |
| 20 | protein localization to endoplasmic reticulum (GO:0070972) | 4.25053359 |
| 21 | telomere maintenance via recombination (GO:0000722) | 4.23733404 |
| 22 | viral life cycle (GO:0019058) | 4.09683839 |
| 23 | cellular protein complex disassembly (GO:0043624) | 4.04735615 |
| 24 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.96763160 |
| 25 | mitotic recombination (GO:0006312) | 3.91525562 |
| 26 | DNA replication checkpoint (GO:0000076) | 3.89617839 |
| 27 | ribosomal large subunit biogenesis (GO:0042273) | 3.80423210 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.78036033 |
| 29 | nucleobase biosynthetic process (GO:0046112) | 3.75458364 |
| 30 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.71171153 |
| 31 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.68992811 |
| 32 | telomere maintenance via telomere lengthening (GO:0010833) | 3.67397276 |
| 33 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.67205816 |
| 34 | IMP biosynthetic process (GO:0006188) | 3.66899976 |
| 35 | protein complex disassembly (GO:0043241) | 3.65619779 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.64937084 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.61581077 |
| 38 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.56669506 |
| 39 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.56669506 |
| 40 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.54875866 |
| 41 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.51337936 |
| 42 | purine nucleobase biosynthetic process (GO:0009113) | 3.45212236 |
| 43 | macromolecular complex disassembly (GO:0032984) | 3.44808610 |
| 44 | IMP metabolic process (GO:0046040) | 3.44423019 |
| 45 | translation (GO:0006412) | 3.41881747 |
| 46 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.38521408 |
| 47 | protein localization to kinetochore (GO:0034501) | 3.32750052 |
| 48 | purine nucleotide salvage (GO:0032261) | 3.31558138 |
| 49 | rRNA processing (GO:0006364) | 3.29640504 |
| 50 | ribosome biogenesis (GO:0042254) | 3.29426534 |
| 51 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.26575371 |
| 52 | positive regulation of granulocyte differentiation (GO:0030854) | 3.24525538 |
| 53 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.22685239 |
| 54 | mRNA catabolic process (GO:0006402) | 3.21655509 |
| 55 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.19598884 |
| 56 | ATP synthesis coupled proton transport (GO:0015986) | 3.19598884 |
| 57 | negative T cell selection (GO:0043383) | 3.19256712 |
| 58 | rRNA metabolic process (GO:0016072) | 3.18837110 |
| 59 | oxidative phosphorylation (GO:0006119) | 3.16806316 |
| 60 | RNA catabolic process (GO:0006401) | 3.16723484 |
| 61 | CENP-A containing nucleosome assembly (GO:0034080) | 3.15032724 |
| 62 | mitotic nuclear envelope disassembly (GO:0007077) | 3.14917272 |
| 63 | chromatin remodeling at centromere (GO:0031055) | 3.14874388 |
| 64 | pseudouridine synthesis (GO:0001522) | 3.13975074 |
| 65 | mature B cell differentiation involved in immune response (GO:0002313) | 3.13779097 |
| 66 | Peyers patch development (GO:0048541) | 3.12424011 |
| 67 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.12424011 |
| 68 | deoxyribose phosphate catabolic process (GO:0046386) | 3.10532767 |
| 69 | spliceosomal snRNP assembly (GO:0000387) | 3.09643557 |
| 70 | mitochondrial calcium ion transport (GO:0006851) | 3.08558954 |
| 71 | positive thymic T cell selection (GO:0045059) | 3.08484384 |
| 72 | negative thymic T cell selection (GO:0045060) | 3.07624546 |
| 73 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.06641572 |
| 74 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.06494442 |
| 75 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.06494442 |
| 76 | regulation of mitochondrial translation (GO:0070129) | 3.05774486 |
| 77 | deoxyribonucleotide catabolic process (GO:0009264) | 3.05327462 |
| 78 | establishment of integrated proviral latency (GO:0075713) | 3.04793895 |
| 79 | ribosome assembly (GO:0042255) | 3.03790810 |
| 80 | DNA replication-independent nucleosome organization (GO:0034724) | 2.97216485 |
| 81 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.97216485 |
| 82 | protein targeting to membrane (GO:0006612) | 2.96423856 |
| 83 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.96163991 |
| 84 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.95316258 |
| 85 | folic acid metabolic process (GO:0046655) | 2.93387552 |
| 86 | regulation of B cell differentiation (GO:0045577) | 2.92670562 |
| 87 | negative regulation of RNA splicing (GO:0033119) | 2.92588367 |
| 88 | protein localization to chromosome, centromeric region (GO:0071459) | 2.92313001 |
| 89 | actin nucleation (GO:0045010) | 2.91040222 |
| 90 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.89961526 |
| 91 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.87547997 |
| 92 | negative regulation of B cell apoptotic process (GO:0002903) | 2.86619090 |
| 93 | membrane disassembly (GO:0030397) | 2.85945593 |
| 94 | nuclear envelope disassembly (GO:0051081) | 2.85945593 |
| 95 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.83314805 |
| 96 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.83253063 |
| 97 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.81612815 |
| 98 | proteasome assembly (GO:0043248) | 2.81486462 |
| 99 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.81480621 |
| 100 | viral mRNA export from host cell nucleus (GO:0046784) | 2.80918129 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80684833 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.80375157 |
| 103 | translesion synthesis (GO:0019985) | 2.80169719 |
| 104 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.79566870 |
| 105 | iron-sulfur cluster assembly (GO:0016226) | 2.79154853 |
| 106 | metallo-sulfur cluster assembly (GO:0031163) | 2.79154853 |
| 107 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78864825 |
| 108 | telomere organization (GO:0032200) | 2.78637880 |
| 109 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77513825 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.77144020 |
| 111 | telomere maintenance (GO:0000723) | 2.76909369 |
| 112 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76814526 |
| 113 | deoxyribose phosphate metabolic process (GO:0019692) | 2.76093584 |
| 114 | DNA duplex unwinding (GO:0032508) | 2.75252944 |
| 115 | cellular component biogenesis (GO:0044085) | 2.74408873 |
| 116 | nucleotide salvage (GO:0043173) | 2.73271244 |
| 117 | DNA geometric change (GO:0032392) | 2.72313866 |
| 118 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70421136 |
| 119 | cell cycle G1/S phase transition (GO:0044843) | 2.70086851 |
| 120 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.70086851 |
| 121 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.68935736 |
| 122 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.68244776 |
| 123 | positive T cell selection (GO:0043368) | 2.67949651 |
| 124 | mitotic metaphase plate congression (GO:0007080) | 2.67787717 |
| 125 | ncRNA 3-end processing (GO:0043628) | 2.66084670 |
| 126 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.65911942 |
| 127 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65144443 |
| 128 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.64962499 |
| 129 | regulation of protein heterodimerization activity (GO:0043497) | 2.64030765 |
| 130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.63742836 |
| 131 | base-excision repair (GO:0006284) | 2.62622938 |
| 132 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.62464031 |
| 133 | negative regulation of ligase activity (GO:0051352) | 2.62464031 |
| 134 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.62110918 |
| 135 | thymic T cell selection (GO:0045061) | 2.61643553 |
| 136 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.58466459 |
| 137 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.58217221 |
| 138 | GDP-mannose metabolic process (GO:0019673) | 2.57958372 |
| 139 | B cell receptor signaling pathway (GO:0050853) | 2.56708334 |
| 140 | respiratory electron transport chain (GO:0022904) | 2.56579087 |
| 141 | immunoglobulin mediated immune response (GO:0016064) | 2.55454869 |
| 142 | autophagic vacuole fusion (GO:0000046) | 2.55447189 |
| 143 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.54896934 |
| 144 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.54882715 |
| 145 | aerobic respiration (GO:0009060) | 2.54198932 |
| 146 | dosage compensation (GO:0007549) | 2.53839030 |
| 147 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.52633329 |
| 148 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.52515107 |
| 149 | mRNA splicing, via spliceosome (GO:0000398) | 2.52399575 |
| 150 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.52399575 |
| 151 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.52304197 |
| 152 | chromatin assembly or disassembly (GO:0006333) | 2.52279235 |
| 153 | postreplication repair (GO:0006301) | 2.51827103 |
| 154 | RNA splicing, via transesterification reactions (GO:0000375) | 2.51649044 |
| 155 | response to interferon-beta (GO:0035456) | 2.50754704 |
| 156 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.50679374 |
| 157 | electron transport chain (GO:0022900) | 2.49860229 |
| 158 | T cell migration (GO:0072678) | 2.46604321 |
| 159 | T cell selection (GO:0045058) | 2.45219142 |
| 160 | mature B cell differentiation (GO:0002335) | 2.42983381 |
| 161 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.42930620 |
| 162 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.42902631 |
| 163 | mast cell activation (GO:0045576) | 2.42171164 |
| 164 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.41372462 |
| 165 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.39788085 |
| 166 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.39788085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.45051378 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.16122398 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.04698026 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15676796 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.89554619 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.81252140 |
| 7 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.74752150 |
| 8 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.68248007 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.61482456 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.59838592 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58890130 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.58255255 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.57283134 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.56419719 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.51268189 |
| 16 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.28647010 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.25501935 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.22374524 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19305269 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.18202621 |
| 21 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17356583 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.14803371 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.13300455 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11291840 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10598643 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.08947239 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98934512 |
| 28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90175459 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.88089592 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87840490 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87826411 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.85659494 |
| 33 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.82496923 |
| 34 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.73396444 |
| 35 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.72978173 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70549622 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70193139 |
| 38 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.65666466 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65045903 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.62782873 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62266148 |
| 42 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61908556 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.59337377 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58139196 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55756727 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52923578 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52531493 |
| 48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.52275432 |
| 49 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50302932 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49857579 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44288102 |
| 52 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43708681 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43564941 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40510434 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.37161166 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36271822 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35856382 |
| 58 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.35846322 |
| 59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33106329 |
| 60 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32097221 |
| 61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31054391 |
| 62 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30729578 |
| 63 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29729475 |
| 64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.29117673 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27253508 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24897009 |
| 67 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24466850 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24313003 |
| 69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.23964402 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22024554 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20876966 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20848774 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20803745 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20290517 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19479991 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18970881 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18036236 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17664613 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17049010 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16879826 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15861323 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15049738 |
| 83 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14970027 |
| 84 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14294286 |
| 85 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14123474 |
| 86 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.13843561 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13007536 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11481313 |
| 89 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.09375336 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05352473 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01900537 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01822661 |
| 93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01150038 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00862971 |
| 95 | * MAF_26560356_Chip-Seq_TH1_Human | 1.00452551 |
| 96 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00275559 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00194677 |
| 98 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99184879 |
| 99 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98328812 |
| 100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97846549 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96530839 |
| 102 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95650729 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95082994 |
| 104 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93032570 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92981171 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92948383 |
| 107 | * MYB_26560356_Chip-Seq_TH2_Human | 0.92777901 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91487787 |
| 109 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.91436149 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.90212668 |
| 111 | MAF_26560356_Chip-Seq_TH2_Human | 0.89710033 |
| 112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87272245 |
| 113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.86968670 |
| 114 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.86422916 |
| 115 | * MYB_26560356_Chip-Seq_TH1_Human | 0.86056771 |
| 116 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84709265 |
| 117 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.84244224 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83929893 |
| 119 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83493515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.58482292 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.75943973 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.71508677 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.61738501 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.55020857 |
| 6 | MP0003077_abnormal_cell_cycle | 3.33519177 |
| 7 | MP0008057_abnormal_DNA_replication | 3.07220934 |
| 8 | MP0008058_abnormal_DNA_repair | 2.59193648 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.56549598 |
| 10 | MP0000490_abnormal_crypts_of | 2.51703013 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.28749752 |
| 12 | MP0005451_abnormal_body_composition | 2.26364361 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.16977501 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.11275222 |
| 15 | MP0008932_abnormal_embryonic_tissue | 2.05276133 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 1.99187741 |
| 17 | MP0001545_abnormal_hematopoietic_system | 1.99187741 |
| 18 | MP0001730_embryonic_growth_arrest | 1.91082477 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.90908807 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 1.90430564 |
| 21 | MP0000350_abnormal_cell_proliferation | 1.85931401 |
| 22 | MP0002398_abnormal_bone_marrow | 1.83592926 |
| 23 | MP0010307_abnormal_tumor_latency | 1.83493117 |
| 24 | MP0000685_abnormal_immune_system | 1.79849755 |
| 25 | MP0002019_abnormal_tumor_incidence | 1.69475842 |
| 26 | MP0003123_paternal_imprinting | 1.66177100 |
| 27 | MP0002722_abnormal_immune_system | 1.64843530 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.60839841 |
| 29 | MP0006054_spinal_hemorrhage | 1.57474522 |
| 30 | MP0000703_abnormal_thymus_morphology | 1.53471002 |
| 31 | MP0000313_abnormal_cell_death | 1.52849134 |
| 32 | MP0003786_premature_aging | 1.48532875 |
| 33 | MP0002429_abnormal_blood_cell | 1.48228331 |
| 34 | MP0001853_heart_inflammation | 1.43760601 |
| 35 | MP0000716_abnormal_immune_system | 1.42962662 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.42669606 |
| 37 | MP0005671_abnormal_response_to | 1.38018246 |
| 38 | MP0002080_prenatal_lethality | 1.36594258 |
| 39 | MP0001800_abnormal_humoral_immune | 1.36153958 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.35042790 |
| 41 | MP0001697_abnormal_embryo_size | 1.33666034 |
| 42 | MP0001819_abnormal_immune_cell | 1.32796603 |
| 43 | MP0003186_abnormal_redox_activity | 1.30489832 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.29835161 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.27782329 |
| 46 | MP0002009_preneoplasia | 1.27305517 |
| 47 | MP0000858_altered_metastatic_potential | 1.26000139 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.25886007 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.24944181 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.24912545 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.23857362 |
| 52 | MP0009697_abnormal_copulation | 1.22577724 |
| 53 | MP0005025_abnormal_response_to | 1.22498083 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.22230221 |
| 55 | MP0002723_abnormal_immune_serum | 1.21893281 |
| 56 | MP0002405_respiratory_system_inflammati | 1.18066574 |
| 57 | MP0009785_altered_susceptibility_to | 1.17979474 |
| 58 | MP0003436_decreased_susceptibility_to | 1.17065427 |
| 59 | MP0005380_embryogenesis_phenotype | 1.14907454 |
| 60 | MP0001672_abnormal_embryogenesis/_devel | 1.14907454 |
| 61 | MP0009840_abnormal_foam_cell | 1.14653775 |
| 62 | MP0003724_increased_susceptibility_to | 1.14614595 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.14152810 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.13105121 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.13060599 |
| 66 | MP0005330_cardiomyopathy | 1.10958479 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 1.10371776 |
| 68 | MP0001873_stomach_inflammation | 1.09113540 |
| 69 | MP0003984_embryonic_growth_retardation | 1.08407673 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.08060057 |
| 71 | MP0000358_abnormal_cell_content/ | 1.06121738 |
| 72 | MP0009278_abnormal_bone_marrow | 1.05754728 |
| 73 | MP0002088_abnormal_embryonic_growth/wei | 1.04654841 |
| 74 | MP0005645_abnormal_hypothalamus_physiol | 1.04336445 |
| 75 | MP0004947_skin_inflammation | 1.04153293 |
| 76 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03884829 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.03848571 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.03061486 |
| 79 | MP0002086_abnormal_extraembryonic_tissu | 1.03046928 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 1.01542625 |
| 81 | MP0002006_tumorigenesis | 1.01393130 |
| 82 | MP0003866_abnormal_defecation | 1.00219453 |
| 83 | MP0002132_abnormal_respiratory_system | 1.00091514 |
| 84 | MP0004197_abnormal_fetal_growth/weight/ | 0.96458818 |
| 85 | MP0005023_abnormal_wound_healing | 0.96105766 |
| 86 | MP0002085_abnormal_embryonic_tissue | 0.95238694 |
| 87 | MP0009763_increased_sensitivity_to | 0.94017302 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.93813331 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.92196126 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 0.91936678 |
| 91 | MP0008260_abnormal_autophagy | 0.91933135 |
| 92 | MP0003303_peritoneal_inflammation | 0.90642298 |
| 93 | MP0003075_altered_response_to | 0.87687968 |
| 94 | MP0005165_increased_susceptibility_to | 0.87143925 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.86458653 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.85717773 |
| 97 | MP0002419_abnormal_innate_immunity | 0.84987883 |
| 98 | MP0002148_abnormal_hypersensitivity_rea | 0.84445286 |
| 99 | MP0002084_abnormal_developmental_patter | 0.84030900 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.82958904 |
| 101 | MP0009764_decreased_sensitivity_to | 0.82500304 |
| 102 | MP0008995_early_reproductive_senescence | 0.81055768 |
| 103 | MP0001764_abnormal_homeostasis | 0.79515427 |
| 104 | MP0000749_muscle_degeneration | 0.78404751 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77636833 |
| 106 | MP0005266_abnormal_metabolism | 0.77442998 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76224013 |
| 108 | MP0001790_abnormal_immune_system | 0.74989202 |
| 109 | MP0005387_immune_system_phenotype | 0.74989202 |
| 110 | MP0003646_muscle_fatigue | 0.73871478 |
| 111 | MP0005166_decreased_susceptibility_to | 0.73254042 |
| 112 | MP0008873_increased_physiological_sensi | 0.72765760 |
| 113 | MP0000598_abnormal_liver_morphology | 0.71395780 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.71280956 |
| 115 | MP0004381_abnormal_hair_follicle | 0.70836445 |
| 116 | MP0006082_CNS_inflammation | 0.70093276 |
| 117 | MP0004036_abnormal_muscle_relaxation | 0.69320720 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.69082039 |
| 119 | MP0005384_cellular_phenotype | 0.69013276 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.68866601 |
| 121 | MP0001293_anophthalmia | 0.68053255 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.67498774 |
| 123 | MP0001851_eye_inflammation | 0.66736251 |
| 124 | MP0008469_abnormal_protein_level | 0.66011531 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.65907496 |
| 126 | MP0008877_abnormal_DNA_methylation | 0.65396494 |
| 127 | MP0001881_abnormal_mammary_gland | 0.64537237 |
| 128 | MP0000371_diluted_coat_color | 0.63339813 |
| 129 | MP0005621_abnormal_cell_physiology | 0.63321582 |
| 130 | MP0001915_intracranial_hemorrhage | 0.63081331 |
| 131 | MP0004147_increased_porphyrin_level | 0.62887728 |
| 132 | MP0001145_abnormal_male_reproductive | 0.62843506 |
| 133 | MP0002210_abnormal_sex_determination | 0.62412262 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.62120549 |
| 135 | MP0003718_maternal_effect | 0.61756475 |
| 136 | MP0005076_abnormal_cell_differentiation | 0.59579225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.14002525 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.98030898 |
| 3 | Reticulocytopenia (HP:0001896) | 5.63859998 |
| 4 | Aplastic anemia (HP:0001915) | 4.25990706 |
| 5 | Thrombocytosis (HP:0001894) | 3.95250029 |
| 6 | Birth length less than 3rd percentile (HP:0003561) | 3.92157479 |
| 7 | Pallor (HP:0000980) | 3.81422343 |
| 8 | Macrocytic anemia (HP:0001972) | 3.75139183 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.69048559 |
| 10 | Colon cancer (HP:0003003) | 3.59847402 |
| 11 | Increased intramyocellular lipid droplets (HP:0012240) | 3.59128481 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 3.50983759 |
| 13 | Increased muscle lipid content (HP:0009058) | 3.38794978 |
| 14 | Rhabdomyolysis (HP:0003201) | 3.22959248 |
| 15 | Microretrognathia (HP:0000308) | 3.22046423 |
| 16 | Oral leukoplakia (HP:0002745) | 3.21604296 |
| 17 | IgM deficiency (HP:0002850) | 3.16873211 |
| 18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.09520190 |
| 19 | Selective tooth agenesis (HP:0001592) | 3.07432321 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.05166140 |
| 21 | Mitochondrial inheritance (HP:0001427) | 3.02876635 |
| 22 | Microvesicular hepatic steatosis (HP:0001414) | 2.98801844 |
| 23 | Multiple enchondromatosis (HP:0005701) | 2.96317850 |
| 24 | Combined immunodeficiency (HP:0005387) | 2.92555063 |
| 25 | Ragged-red muscle fibers (HP:0003200) | 2.88771110 |
| 26 | Obstructive lung disease (HP:0006536) | 2.88718240 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88718240 |
| 28 | T lymphocytopenia (HP:0005403) | 2.86507752 |
| 29 | Acute necrotizing encephalopathy (HP:0006965) | 2.84390382 |
| 30 | 11 pairs of ribs (HP:0000878) | 2.83573354 |
| 31 | Meningitis (HP:0001287) | 2.76832186 |
| 32 | Petechiae (HP:0000967) | 2.76385558 |
| 33 | Abnormality of the prostate (HP:0008775) | 2.76109205 |
| 34 | Exercise-induced myalgia (HP:0003738) | 2.71469599 |
| 35 | Increased CSF lactate (HP:0002490) | 2.70200894 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.69243310 |
| 37 | Granulocytopenia (HP:0001913) | 2.68845559 |
| 38 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.68767597 |
| 39 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.68767597 |
| 40 | Breast hypoplasia (HP:0003187) | 2.68047188 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 2.65607232 |
| 42 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.65180059 |
| 43 | Acute encephalopathy (HP:0006846) | 2.62874481 |
| 44 | Increased IgM level (HP:0003496) | 2.62476648 |
| 45 | Chronic otitis media (HP:0000389) | 2.61579778 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.59886673 |
| 47 | Chromsome breakage (HP:0040012) | 2.59640183 |
| 48 | Type I transferrin isoform profile (HP:0003642) | 2.58268513 |
| 49 | Degeneration of anterior horn cells (HP:0002398) | 2.57326058 |
| 50 | Abnormality of the anterior horn cell (HP:0006802) | 2.57326058 |
| 51 | Nemaline bodies (HP:0003798) | 2.56586853 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55966573 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.54047273 |
| 54 | IgG deficiency (HP:0004315) | 2.50772713 |
| 55 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.50407355 |
| 56 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.50309979 |
| 57 | Myelodysplasia (HP:0002863) | 2.49211867 |
| 58 | Rough bone trabeculation (HP:0100670) | 2.46489848 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.44768413 |
| 60 | Colitis (HP:0002583) | 2.43641936 |
| 61 | Trismus (HP:0000211) | 2.42607778 |
| 62 | Absent thumb (HP:0009777) | 2.42571592 |
| 63 | Abnormality of reticulocytes (HP:0004312) | 2.42138095 |
| 64 | Lactic acidosis (HP:0003128) | 2.40931701 |
| 65 | Encephalitis (HP:0002383) | 2.40505722 |
| 66 | Pancytopenia (HP:0001876) | 2.39535476 |
| 67 | Exercise intolerance (HP:0003546) | 2.37956043 |
| 68 | Stomatitis (HP:0010280) | 2.37591845 |
| 69 | Agnosia (HP:0010524) | 2.36891347 |
| 70 | Lymphoma (HP:0002665) | 2.33859229 |
| 71 | Cerebral palsy (HP:0100021) | 2.33746458 |
| 72 | Muscle fiber inclusion bodies (HP:0100299) | 2.33415650 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32483194 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32483194 |
| 75 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.31820222 |
| 76 | Myoglobinuria (HP:0002913) | 2.31334712 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.31159608 |
| 78 | Abnormality of chromosome stability (HP:0003220) | 2.30002191 |
| 79 | Increased hepatocellular lipid droplets (HP:0006565) | 2.28908715 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.28009394 |
| 81 | Abnormality of T cells (HP:0002843) | 2.27769126 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.27554927 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27554927 |
| 84 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.27140078 |
| 85 | Bone marrow hypocellularity (HP:0005528) | 2.26751734 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.26628363 |
| 87 | 3-Methylglutaconic aciduria (HP:0003535) | 2.25526759 |
| 88 | Mediastinal lymphadenopathy (HP:0100721) | 2.25205858 |
| 89 | Progressive macrocephaly (HP:0004481) | 2.24446441 |
| 90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23764261 |
| 91 | Acute hepatic failure (HP:0006554) | 2.22596921 |
| 92 | Abnormality of the preputium (HP:0100587) | 2.22102390 |
| 93 | Recurrent abscess formation (HP:0002722) | 2.21131510 |
| 94 | Progressive muscle weakness (HP:0003323) | 2.20991551 |
| 95 | Ependymoma (HP:0002888) | 2.20114057 |
| 96 | Premature graying of hair (HP:0002216) | 2.19991859 |
| 97 | Lipid accumulation in hepatocytes (HP:0006561) | 2.19575516 |
| 98 | Poikiloderma (HP:0001029) | 2.19513998 |
| 99 | Slender long bone (HP:0003100) | 2.18923819 |
| 100 | Renal Fanconi syndrome (HP:0001994) | 2.18377152 |
| 101 | Muscle stiffness (HP:0003552) | 2.18237485 |
| 102 | Neoplasm of the pancreas (HP:0002894) | 2.18085211 |
| 103 | Poor head control (HP:0002421) | 2.17804483 |
| 104 | Meckel diverticulum (HP:0002245) | 2.15076715 |
| 105 | Medulloblastoma (HP:0002885) | 2.13523432 |
| 106 | Abnormal protein glycosylation (HP:0012346) | 2.12118209 |
| 107 | Abnormal glycosylation (HP:0012345) | 2.12118209 |
| 108 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12118209 |
| 109 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12118209 |
| 110 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.10274123 |
| 111 | Cellulitis (HP:0100658) | 2.09618983 |
| 112 | Abnormality of the ileum (HP:0001549) | 2.08909468 |
| 113 | Cerebral edema (HP:0002181) | 2.08546648 |
| 114 | Prostate neoplasm (HP:0100787) | 2.08199758 |
| 115 | Fatigue (HP:0012378) | 2.07919808 |
| 116 | Eczematoid dermatitis (HP:0000976) | 2.04778239 |
| 117 | Cerebral hypomyelination (HP:0006808) | 2.03937874 |
| 118 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.01659870 |
| 119 | Testicular atrophy (HP:0000029) | 2.01550510 |
| 120 | Neck muscle weakness (HP:0000467) | 2.00655748 |
| 121 | Hypertensive crisis (HP:0100735) | 2.00480704 |
| 122 | Increased IgE level (HP:0003212) | 2.00434147 |
| 123 | Hypergammaglobulinemia (HP:0010702) | 2.00155068 |
| 124 | Rhabdomyosarcoma (HP:0002859) | 1.99187217 |
| 125 | Recurrent viral infections (HP:0004429) | 1.99022698 |
| 126 | Epistaxis (HP:0000421) | 1.98884849 |
| 127 | Panhypogammaglobulinemia (HP:0003139) | 1.98139201 |
| 128 | Amaurosis fugax (HP:0100576) | 1.94472127 |
| 129 | Patellar aplasia (HP:0006443) | 1.93986866 |
| 130 | Recurrent bronchitis (HP:0002837) | 1.93258303 |
| 131 | B lymphocytopenia (HP:0010976) | 1.90833000 |
| 132 | Abnormality of B cell number (HP:0010975) | 1.90833000 |
| 133 | Increased serum lactate (HP:0002151) | 1.89479085 |
| 134 | Prominent nose (HP:0000448) | 1.89151747 |
| 135 | Hepatic necrosis (HP:0002605) | 1.88523524 |
| 136 | Hepatocellular necrosis (HP:0001404) | 1.87380478 |
| 137 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.87220734 |
| 138 | Carpal bone hypoplasia (HP:0001498) | 1.86346942 |
| 139 | Acute lymphatic leukemia (HP:0006721) | 1.85902969 |
| 140 | Cellular immunodeficiency (HP:0005374) | 1.83928922 |
| 141 | Impaired platelet aggregation (HP:0003540) | 1.79589052 |
| 142 | Abnormal platelet function (HP:0011869) | 1.79589052 |
| 143 | Calcaneovalgus deformity (HP:0001848) | 1.79128231 |
| 144 | Squamous cell carcinoma (HP:0002860) | 1.78758911 |
| 145 | Muscle fiber atrophy (HP:0100295) | 1.77649220 |
| 146 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77623087 |
| 147 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.77244206 |
| 148 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.77140244 |
| 149 | High pitched voice (HP:0001620) | 1.77023889 |
| 150 | Abnormality of the calcaneus (HP:0008364) | 1.73949377 |
| 151 | Abnormality of DNA repair (HP:0003254) | 1.73029310 |
| 152 | Increased serum ferritin (HP:0003281) | 1.72974321 |
| 153 | Pulmonary fibrosis (HP:0002206) | 1.71478156 |
| 154 | Tracheoesophageal fistula (HP:0002575) | 1.70110323 |
| 155 | Megaloblastic anemia (HP:0001889) | 1.69606292 |
| 156 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.69018519 |
| 157 | Myositis (HP:0100614) | 1.64920802 |
| 158 | Prolonged bleeding time (HP:0003010) | 1.64164770 |
| 159 | Abnormal number of incisors (HP:0011064) | 1.64052753 |
| 160 | Leukopenia (HP:0001882) | 1.63695480 |
| 161 | Small intestinal stenosis (HP:0012848) | 1.63478564 |
| 162 | Duodenal stenosis (HP:0100867) | 1.63478564 |
| 163 | Missing ribs (HP:0000921) | 1.61655382 |
| 164 | Sloping forehead (HP:0000340) | 1.61534305 |
| 165 | Abnormal trabecular bone morphology (HP:0100671) | 1.60917828 |
| 166 | Neoplasm of the colon (HP:0100273) | 1.60877548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.42022232 |
| 2 | WEE1 | 3.41996614 |
| 3 | NME2 | 3.38058226 |
| 4 | CDC7 | 3.37877839 |
| 5 | BUB1 | 3.11934436 |
| 6 | EIF2AK1 | 2.61054563 |
| 7 | EEF2K | 2.58991709 |
| 8 | MAP4K1 | 2.27199363 |
| 9 | NEK2 | 2.26299301 |
| 10 | STK16 | 2.22826685 |
| 11 | TESK2 | 2.21246169 |
| 12 | FLT3 | 2.05301429 |
| 13 | PASK | 2.04342438 |
| 14 | ACVR1B | 2.04326458 |
| 15 | BRSK2 | 2.01720029 |
| 16 | TXK | 2.01149432 |
| 17 | RPS6KB2 | 1.95842992 |
| 18 | MAP3K10 | 1.89637239 |
| 19 | EIF2AK3 | 1.86413235 |
| 20 | PKN2 | 1.85372350 |
| 21 | RPS6KA4 | 1.78104921 |
| 22 | DYRK3 | 1.75557824 |
| 23 | PIM2 | 1.71098756 |
| 24 | FES | 1.69781481 |
| 25 | TAOK3 | 1.67886522 |
| 26 | VRK1 | 1.62403018 |
| 27 | KDR | 1.59295540 |
| 28 | MAP3K12 | 1.57958355 |
| 29 | TLK1 | 1.54913222 |
| 30 | PRPF4B | 1.49336545 |
| 31 | CDK7 | 1.48007096 |
| 32 | SRPK1 | 1.47706933 |
| 33 | LRRK2 | 1.43891735 |
| 34 | RIPK4 | 1.42736932 |
| 35 | PAK4 | 1.37460459 |
| 36 | KIT | 1.36524323 |
| 37 | MAP2K3 | 1.35867936 |
| 38 | ATR | 1.35784370 |
| 39 | PLK1 | 1.34275813 |
| 40 | TGFBR1 | 1.34201584 |
| 41 | BTK | 1.33640396 |
| 42 | AURKB | 1.29334140 |
| 43 | NEK1 | 1.29289114 |
| 44 | BCKDK | 1.28940721 |
| 45 | TTK | 1.28526016 |
| 46 | MAP3K8 | 1.25713427 |
| 47 | CDK4 | 1.24768709 |
| 48 | IKBKE | 1.24628996 |
| 49 | TRIB3 | 1.24364254 |
| 50 | STK10 | 1.20583936 |
| 51 | MAPKAPK3 | 1.20557877 |
| 52 | ZAP70 | 1.20534337 |
| 53 | TSSK6 | 1.16022046 |
| 54 | PLK4 | 1.14289966 |
| 55 | DAPK1 | 1.11550527 |
| 56 | PIK3CG | 1.08161349 |
| 57 | MAP3K11 | 1.08100492 |
| 58 | TESK1 | 1.07513931 |
| 59 | SMG1 | 1.07458755 |
| 60 | ERN1 | 1.07405744 |
| 61 | BRSK1 | 1.06505340 |
| 62 | PIM1 | 1.05646305 |
| 63 | TEC | 1.02426677 |
| 64 | TNK2 | 1.00893049 |
| 65 | BMPR2 | 0.99787727 |
| 66 | CSF1R | 0.98753503 |
| 67 | AURKA | 0.98563445 |
| 68 | BLK | 0.98149597 |
| 69 | TYK2 | 0.97492626 |
| 70 | MAP3K14 | 0.97005285 |
| 71 | MAP3K13 | 0.92476214 |
| 72 | ARAF | 0.92010528 |
| 73 | OBSCN | 0.91890928 |
| 74 | GRK6 | 0.91200862 |
| 75 | ILK | 0.88834844 |
| 76 | NUAK1 | 0.87899044 |
| 77 | CHEK2 | 0.87806889 |
| 78 | IRAK3 | 0.85506615 |
| 79 | JAK3 | 0.85392497 |
| 80 | STK4 | 0.80845439 |
| 81 | CDK19 | 0.79261604 |
| 82 | MKNK1 | 0.78631035 |
| 83 | PBK | 0.75417823 |
| 84 | CHEK1 | 0.73215714 |
| 85 | MAPKAPK5 | 0.72186835 |
| 86 | TBK1 | 0.71624981 |
| 87 | MST4 | 0.69326237 |
| 88 | CCNB1 | 0.66070482 |
| 89 | PAK1 | 0.63106983 |
| 90 | IRAK4 | 0.60629526 |
| 91 | CSNK2A2 | 0.56761506 |
| 92 | HCK | 0.56683482 |
| 93 | CDK8 | 0.56127314 |
| 94 | ZAK | 0.55326763 |
| 95 | CDK12 | 0.54904279 |
| 96 | PRKCQ | 0.54652819 |
| 97 | RAF1 | 0.54575084 |
| 98 | SYK | 0.53432422 |
| 99 | MAP3K1 | 0.52781288 |
| 100 | CDK2 | 0.52544749 |
| 101 | CSNK2A1 | 0.51932277 |
| 102 | LIMK1 | 0.50500711 |
| 103 | IKBKB | 0.47845591 |
| 104 | MUSK | 0.46843644 |
| 105 | ATM | 0.46730339 |
| 106 | MAP4K2 | 0.46269530 |
| 107 | TRPM7 | 0.45170164 |
| 108 | MAPK11 | 0.43790442 |
| 109 | RPS6KA5 | 0.43208536 |
| 110 | MAP2K2 | 0.42628096 |
| 111 | LYN | 0.42429565 |
| 112 | EIF2AK2 | 0.42401762 |
| 113 | MAPK12 | 0.41510684 |
| 114 | BRAF | 0.40715706 |
| 115 | CLK1 | 0.40675862 |
| 116 | CSNK1G3 | 0.38917378 |
| 117 | NLK | 0.37606984 |
| 118 | PLK3 | 0.37528381 |
| 119 | MYLK | 0.37459367 |
| 120 | LCK | 0.36469569 |
| 121 | MAPKAPK2 | 0.36195228 |
| 122 | AKT2 | 0.35856632 |
| 123 | MATK | 0.35854826 |
| 124 | EPHA2 | 0.35817926 |
| 125 | MAP3K5 | 0.35339965 |
| 126 | ABL2 | 0.35082631 |
| 127 | MAP2K6 | 0.34364622 |
| 128 | TAOK2 | 0.33762122 |
| 129 | DAPK3 | 0.33580054 |
| 130 | CDK6 | 0.33268135 |
| 131 | ALK | 0.32796794 |
| 132 | MAP3K3 | 0.32641607 |
| 133 | PAK2 | 0.31632993 |
| 134 | ITK | 0.30208533 |
| 135 | RPS6KA6 | 0.29958103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.35259547 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.47554966 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 4.06968687 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.16288699 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.01406218 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.91290781 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.82535133 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.77401256 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.68729600 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.66951608 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.51144712 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.43562329 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.42195233 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.37114638 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.29086740 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.14283218 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13092252 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.11450287 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.07871358 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03264020 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.89329081 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.69734461 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64513038 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.61241070 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.46142259 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.36874772 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35760302 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34428887 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30158812 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29674092 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26251850 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.22624751 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.22208414 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.19409360 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18888203 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.17878539 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14647725 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11339682 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09779602 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08862628 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08438364 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06313458 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.05208177 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02802748 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98797616 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92020704 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90272920 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88876441 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83774259 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83235197 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.82091349 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79406228 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79264265 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78759621 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74457833 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.71147443 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69873060 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69586506 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69176368 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.68834944 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.68674241 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68468704 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68151209 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65453757 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62321458 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.61830583 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61096588 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60273547 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.59593386 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59123029 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57658493 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57286478 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56147897 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53167552 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51768147 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51226774 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49922422 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.49466930 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48780968 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48484519 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47860798 |
| 82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47822443 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46596133 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46097370 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.45904922 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45688802 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45486615 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44284206 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43276835 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41517448 |
| 91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41360178 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.41088117 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38890105 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37934237 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37601976 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37248997 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.34790355 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.34497674 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33769279 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32722610 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.31949456 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31086440 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31012440 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30877033 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30633295 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30495207 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29730906 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29465551 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28008785 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27837710 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27766336 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27108942 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.26344118 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25647922 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24750191 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24039861 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23763968 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23566774 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22434223 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21802608 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21702140 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21659981 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.21510533 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18181621 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.17357639 |

